Shanghai, China

Jie Zhao

This inventor holds 36 USPTO granted patents and 20 published patent applications and 5 EPO patents, primarily in Biopharmaceuticals. Top assignees: Semiconductor Manufacturing International (Shanghai) Corporation, Semiconductor Manufacturing International (Beijing) Corporation, Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jie Zhao. Retrieved from https://idiyas.com/inventor/jie-zhao-8wr023c8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 36 

% Patents Active = 97.2

 

Average Co-Inventor Count = 1.9

ph-index = 5

Forward Citations = 85(Granted Patents)


Company Filing History:


Years Active: 2010-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Bispecific Antibody
CD38 Antibody
IL-4R Antibody
IL-5 Antibody
PD-1 Antibody
Gellan Gum
Dielectric Reliability
CMOS Device
Transistor Fabrication
Semiconductor Device
Fermentation Process
Parallel-Computational Database
36 patents (USPTO):Explore Patents

Title: Jie Zhao: Innovator in Semiconductor Technology and Biopharmaceuticals

Introduction: Jie Zhao is an accomplished inventor based in Shanghai, China, known for his significant contributions to the fields of semiconductor technology and biopharmaceuticals. With a remarkable portfolio of 32 patents, Zhao's inventions demonstrate his expertise and innovative spirit.

Latest Patents: Among his latest patents, two notable inventions stand out. The first is a patent for a “Circuit and control method for preventing false turn-on of semiconductor switching device.” This innovative circuit incorporates an active clamp circuit, control circuit, power amplifier circuit, and suppression circuit, meticulously designed to enhance the reliability of semiconductor switching devices by preventing false turn-ons. The second patent focuses on “Antibodies binding to human IL-4R, preparation method therefor and use thereof.” This technology details antibodies that specifically bind to human IL-4R, with differences in constant regions affecting their activity and addressing diseases related to IL-4R overexpression, such as atopic dermatitis and asthma. Both patents highlight Zhao's ability to bridge the gap between technology and medicine.

Career Highlights: Jie Zhao has made significant strides in his career by working for notable companies, including Semiconductor Manufacturing International (Shanghai) Corporation and Semiconductor Manufacturing International (Beijing) Corporation. His roles in these organizations have further solidified his reputation as an innovative thinker in the semiconductor industry.

Collaborations: Throughout his career, Zhao has collaborated with talented individuals such as Youneng Xiao and Jiaqi Yang. These professional partnerships have fostered an environment of creativity and idea exchange, leading to groundbreaking inventions.

Conclusion: Jie Zhao's impressive array of patents underscores his impact on both semiconductor technology and biopharmaceuticals. His work not only advances technological innovation but also holds promise for improving healthcare outcomes. As he continues to innovate, Zhao remains a key figure in these dynamic fields.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…